GoldBamboo.com - Knowledge is strong medicine
  

Project Friendship - Article


  Not Signed In - Sign In / Register







[ Disclaimer: The information on GoldBamboo for any particular treatment, medicine, drug, or herbal product might be missing or incomplete, and should never be used as a single source of knowledge. GoldBamboo generally has links to authoritative sites displayed toward the bottom of each topic page under the heading "Resources". ]

Drinking Water

Water




Clinical Trial: Project Friendship

This study is not yet open for patient recruitment.

Sponsors and Collaborators: National Institute of Child Health and Human Development (NICHD)
National Institute on Drug Abuse (NIDA)
National Institute of Mental Health (NIMH)
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Information provided by: National Institute of Child Health and Human Development (NICHD)

Purpose

Social networks are thought to hold potential for shaping behavior on the grounds that social and situational factors more strongly influence behavior than do personality variables. This is a behavioral intervention study that will test a 6-session, small-group, peer-network intervention among adolescent males and females and their friends. The intervention primarily focuses on reducing risky sexual behavior and increasing condom use among adolescent males and females, aged 16-19. The concurrent use of alcohol and marijuana during sex is also a focus as these two substances are widely used among adolescents and fuel risky sexual behavior.

Condition Treatment or Intervention Phase
Sexual Behavior
Alcohol Drinking
Marijuana Smoking
 Behavior: Adolescent Safer Sex Social Network Intervention
Phase II

MedlinePlus related topics:  Alcohol Consumption;   Smoking

Study Type: Interventional
Study Design: Treatment, Non-Randomized, Open Label, Uncontrolled, Single Group Assignment, Efficacy Study

Official Title: Adolescent Safer Sex Social Network Intervention

Further Study Details: 
Primary Outcomes: Sexual behavior will be measured by the self-reported number of unprotected (not protected with male or female condom) vaginal, oral and anal sex acts among all (index and network members) who receive the intervention.; Sexual acts when drunk or high will be measured by counting the number of sexual encounters that occurred concurrent with a respondent reporting being “drunk” or “high”.; Alcohol use will be measured by calculating the mean number of drinks consumed.; Data at each of the three time points (Baseline, 3 and 6 months) will be evaluated to determine whether sexual and drug-use behaviors within networks are more correlated than such behaviors between networks.
Expected Total Enrollment:  200

The objective of this Phase II study is to test the feasibility, acceptability and preliminary effectiveness of a 6-session, small-group, peer-network intervention among adolescent males and females and their friendship networks.

A one-arm intervention design with pre-test assessments within one month before the first intervention session, and with post-test assessments at three and six months following intervention completion will be used. The intervention will be delivered to cohorts of friendship groups comprised of an index friend and their social network. To ensure that baseline data reflect recent, pre-intervention behavior, index participants and their networks will be recruited in small ‘cohorts’ of 8-16 (average 12) adolescents at a time. This cohort will then receive the group intervention at the same time. Each cohort of interested and eligible participants (index + network members) will be screened, consented, and provide baseline data. The first intervention session must occur within one month of baseline data collection. A successive series of these small cohorts will be identified, enrolled and dispatched to receive the intervention with subsequent follow up timelines determined by the date of the final group session of each cohort.

Preliminary effectiveness of the behavioral intervention will be measured as follows:

  • The primary outcome related to sexual behavior is the self-reported number of unprotected (not protected with male or female condom) vaginal, oral and anal sex acts among all (index and network members) who receive the intervention.
  • Sexual acts when drunk or high will be measured by counting the number of sexual encounters that occurred concurrent with a respondent reporting being “drunk” or “high”.
  • Alcohol use will be measured by calculating the mean number of drinks consumed.

The network effect on sexual and drug-use behaviors will be measured as follows:

  • Data at each of the three time points (Baseline, 3 and 6 months) will be evaluated to determine whether sexual and drug-use behaviors within networks are more correlated than such behaviors between networks.

Eligibility

Ages Eligible for Study:  16 Years   -   19 Years,  Genders Eligible for Study:  Both

Accepts Healthy Volunteers

Criteria

Inclusion Criteria:

Index Participant Inclusion Criteria

  • Self-identifies as all or part “Latino”
  • Age is between 16 years and 0 days and 19 years and 364 days at the time of study enrollment
  • In the past 3 months, reports engaging in any type of heterosexual sex (vaginal, oral or anal) with an opposite-sex partner
  • In the past 3 months, reports any of the following: *alcohol use at least once; *marijuana use at least once; *having sex while drunk or high
  • Must understand spoken and written English sufficiently to provide consent/assent and be interviewed and attend intervention workshops delivered in English
  • Must live in the Boston or Tampa area, and plan to be available for study appointments (vacation allowed if not interfering with the planned intervention or follow up dates)

Network Participant Inclusion Criteria

  • Age is between 16 years and 0 days to 19 years and 364 days at the time of study enrollment
  • In the past 3 months, reports engaging in any type of heterosexual sex (vaginal, oral or anal) with an opposite-sex partner
  • Must understand spoken and written English sufficiently to provide consent/assent and be interviewed and attend intervention workshops delivered in English
  • Must live in the Boston or Tampa area, and plan to be available for study appointments (vacation allowed if not interfering with the planned intervention or follow up dates)
  • Must be reported by an index as a friend who: *has been known for at least 6 months; *hangs out with, or is in contact with the index at least 2 times per week; *has engaged in alcohol or marijuana use with the index during the last 3 months; and, *gave directive guidance (gave index information on how to do something) AND, had intimate interaction (i.e. listened to private feelings of index) AND, had positive social interaction with the index.

Exclusion Criteria:

Index Participant Exclusion Criteria

  • Reports only same sex behavior
  • Reports being HIV positive, as measured by self-report
  • Reports having engaged in behaviors in the past year that are defined as “severe” physical abuse of others on the Conflict Tactics Scale
  • In the past year, reports having made someone engage in sexual things that he or she did not want to do either by holding the partner down, hurting or by threatening them in some way
  • Unable to nominate at least one eligible friend to participate in the intervention
  • Reports having ever used heroin, crack, cocaine, or methamphetamines
  • Reports alcohol dependence as measured by affirmative answers to 3 or more out of 7 questions on the DSM-IV based criteria of substance dependence
  • Reports marijuana dependence as measured by affirmative answers to 3 or more out of 7 questions on the DSM-IV based criteria of substance dependence
  • Reports being an active member of a gang
  • Reports or is known by staff to be currently participating in any other bio-medical or Adolescent Trial Network (ATN)-related intervention study or trial
  • If female, reports being currently pregnant
  • Unwilling to be screened for sexually transmitted infections (STIs)
  • Prior participation in this study intervention as either an index or a network member as determined by review of study logs

Network Participant Exclusion Criteria

  • Is currently romantically involved with the index who named them
  • Has ever had vaginal, oral or anal sex with the index
  • Reports only same sex behavior
  • Reports being HIV positive, as measured by self-report
  • Reports having engaged in behaviors in the past year that are defined as “severe” physical abuse of others on the Conflict Tactics Scale
  • In the past year, reports having made someone engage in sexual things that he or she did not want to do either by holding the partner down, hurting or by threatening them in some way
  • Reports having ever used heroin, crack, cocaine, or methamphetamines
  • Reports alcohol dependence as measured by affirmative answers to 3 or more out of 7 questions on the DSM-IV based criteria of substance dependence
  • Reports marijuana dependence as measured by affirmative answers to 3 or more out of 7 questions on the DSM-IV based criteria of substance dependence
  • Self-reports being an active member of a gang
  • Reports or is known by staff to be currently participating in any other bio-medical or ATN-related intervention study or trial
  • If female, reports being currently pregnant
  • Unwilling to be screened for STIs
  • Prior participation in this study intervention as either an index or a network participant as determined by review of study logs

Location Information

Julie Davidson, MSN      301-610-5521    JulieDavidson@westat.com

Florida
      University of South Florida College of Medicine, Tampa,  Florida,  33606,  United States
Silvia Callejas, BSN  813-259-8800    scalleja@hsc.usf.edu 
Priscilla Julian, RN  813-259-8613    pjulian@hsc.usf.edu 
Patricia Emmanuel, MD,  Principal Investigator

Massachusetts
      Children's Hospital of Boston, Boston,  Massachusetts,  02115,  United States
Cindy Diggs, BA  617-355-7528    cindy.diggs@childrens.harvard.edu 
Susan Sommer, MSN  617-355-5592    susan.sommer@childrens.harvard.edu 
Cathryn Samples, MD, MPH,  Principal Investigator

Study chairs or principal investigators

Mary Latka, PhD,  Study Chair

More Information

Study ID Numbers:  ATN 032
Record last reviewed:  April 2005
Last Updated:  April 6, 2005
Record first received:  April 5, 2005
ClinicalTrials.gov Identifier:  NCT00107562
Health Authority: United States: Federal Government
ClinicalTrials.gov processed this record on 2005-04-08


Source: ClinicalTrials.gov
Cache Date: April 9, 2005

Resources



Take control over your directory listings...INSTANTLY

Every day, thousands of users find businesses like yours in the GoldBamboo directory.

Limited Time Offer!!!

For only $50 a year, a savings of 50% off our standard rate:

  • Edit your listing (whenever you want!)
  • Link to your website
  • Choose which categories you are listed in
  • Describe your services

The process will take only a few minutes and consists of 3 easy steps:

1. Register     >     2. Edit Listings     >     3. Publish

Your Company
your street
yourtown, YS 12345
888-888-8888



No Thanks

Popular Treatments

Acne Treatment ADHD Treatment Allergy Treatment Alzheimer's Treatment
Anemia Treatment Arthritis Treatment Asthma Treatment Bipolar Disorder Treatment
Bird Flu Treatment Bladder Cancer Treatment Bladder Control Treatment Blood Pressure Treatment
Brain Tumor Treatment Breast Cancer Treatment Bronchitis Treatment Cancer Treatment
Cancer Alternative Treatment Cataract Treatment Cirrhosis Treatment Colitis Treatment
Colon Cancer Treatment Common Cold Treatment Conjunctivitis Treatment Constipation Treatment
Crohn's Disease Treatment Cystic Fibrosis Treatment Depression Treatment Dermatitis Treatment
Diabetes Treatment Edema Treatment Epilepsy Treatment Erectile Dysfunction Treatment
Fibromyalgia Treatment GERD Treatment Glaucoma Treatment Gout Treatment
Hay Fever Treatment Headache Treatment Heart Disease Treatment Hepatitis Treatment
High Blood Pressure Treatment High Cholesterol Treatment Hives Treatment Hypertension Treatment
Hypoglycemia Treatment IBS Treatment Impotence Treatment Indigestion Treatment
Infertility Treatment Influenza Treatment Insomnia Treatment Lactose Intolerance Treatment
Leukemia Treatment Lung Cancer Treatment Lyme Disease Treatment Macular Degeneration Treatment
Menopause Treatment Migraine Treatment Osteoarthritis Treatment Osteoporosis Treatment
Pancreatic Cancer Treatment PMS Treatment Pneumonia Treatment Prostate Diseases Treatment
Restless Leg Treatment Rheumatoid Arthritis Treatment Sepsis Treatment Sinusitis Treatment
Skin Cancer Treatment Sleep Apnea Treatment Snoring Treatment Stroke Treatment
Testicular Cancer Treatment
GoldBambooTM

Your Integrative Health and Wellness Resource for Drinking Water.

December 5, 2008



Page Updated: September 6, 2005
============== Advertisement ==============
Disclaimer: All material displayed on the GoldBamboo.com website is provided for educational purposes only. Consult a physician regarding the applicability of any information found on GoldBamboo.com to your symptoms or medical condition.

Home | About Us | Link To Us | Feedback | Disclaimer | Privacy Policy | Terms of Use | Health Forums

Copyright © 2004-2008 - Gold Bamboo LLC - All rights reserved.

HONcode accreditation seal.

We comply with the HONcode standard for health trust worthy information:
verify here.